Metabolism of oxygen derivatives has been shown to be altered in Down syndrome (DS) due to the overexpression of the Cu/Zn superoxide dismutase gene ( SOD -1) on chromosome 21. Transgenic mice for the human SOD 1 gene (h SOD 1) exhibit some features of the syndrome. Oxidation of proteins and oxidative stress are involved in normal and pathological aging. The proteasome is an adaptative system to eliminate the modified proteins which can be deleterious. As SOD 1 overexpression has been shown to be either deleterious or protective according to tissues and paradigms, we have measured in function of age the 20S proteasome activities in neural tissues (cerebral hemisphere, cerebellum and cortex) and in the thymus and the heart from control and transgenic mice. Indeed, although SOD 1 overexpression is very deleterious in thymus and heart, it has little effect in cerebral hemisphere and cortex depending on the proteolytic activity measured. Conversely in the cerebellum the three proteolytic activities decrease dramatically in transgenic old mice while it was not modified in control mice during aging. The results of this study suggest that some phenotypes of DS present in thymus, heart and neural tissues of h SOD 1 transgenic mice might be partially due to the modulation of the 20S proteasome expression during aging.
Sinet, P.M. (1982) Metabolism of Oxygen Derivatives in Down’s Syndrome. Annals of the New York Academy of Sciences, 396, 83-94. http://dx.doi.org/10.1111/j.1749-6632.1982.tb26845.x
Reynolds, G.P. and Cutts, A.J. (1993) Free Radical Damage in Down’s Syndrome Brain. Biochemical Society Transactions, 21, 221S. http://dx.doi.org/10.1042/bst021221s
De Haan, J.B., Wolvetang, E.J., Cristiano, F., Iannello, R., Bladier, C., Kelner, M.J. and Kola, I. (1997) Reactive Oxygen Species and Their Contribution to Pathology in Down Syndrome. Advances in Pharmacology, 38, 379-402. http://dx.doi.org/10.1016/S1054-3589(08)60992-8
Lott, I.T. (2012) Antioxidants in Down Syndrome. Biochimica et Biophysica Acta, 1822, 657-663. http://dx.doi.org/10.1016/j.bbadis.2011.12.010
He, J., Li, T., Chen, J., Liu, Y., Xiong, F., Yang, J. and Song, C. (2016) Plasma Antioxidant Enzymes and Lipoperoxidation Status in Children with Down Syndrome. Clinical Biochemistry, 49, 61-65. http://dx.doi.org/10.1016/j.clinbiochem.2015.08.026
Garlet, T.R., Parisotto, E.B., de Medeiros Gda, S., Pereira, L.C., Moreira, E.A., Dalmarco, E.M., Dalmarco, J.B. and Wilhelm Filho, D. (2013) Systemic Oxidative Stress in Children and Teenagers with Down Syndrome. Life Sciences, 93, 558-563. http://dx.doi.org/10.1016/j.lfs.2013.08.017
Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C. and Groner, Y. (1987) Transgenic Mice with Increased Cu/Zn-Superoxide Dismutase Activity: Animal Model of Dosage Effects in Down Syndrome. Proceedings of the National Academy of Sciences, 84, 8044-8048. http://dx.doi.org/10.1073/pnas.84.22.8044
Ceballos-Picot, I., Nicole, A., Clement, M., Bourre, J.M. and Sinet, P.M. (1992) Age-Related Changes in Antioxidant Enzymes and Lipid Peroxidation in Brains of Control and Transgenic Mice Overexpressing Copper-Zinc Superoxide Dismutase. Mutation Research, 275, 281-293. http://dx.doi.org/10.1016/0921-8734(92)90032-K
London, J., Paris, D., Toyama, K., Paly, E., Casanova, M. and Sinet, P.M. (1993) The Use of FVB: Ninbred Strain to Generate and Study of Transgenic Mice Expressing High Level of Cu:Zn SOD-1. Biology of the Cell, 77, 335.
Nabarra, B., Casanova, M., Paris, D., Nicole, A., Toyama, K., Sinet, Ceballos, I. and London, J. (1996) Transgenic Mice Overexpressing the Human Cu/Zn-SOD Gene: Ultrastructural Studies of a Premature Thymic Involution Model of Down’s Syndrome (Trisomy 21). Laboratory Investigation, 74, 617-626.
Laurent, J., Paly, E., Marche, P.N. and London, J. (2006) Early Thymic T Cell Development in Young Transgenic Mice Overexpressing Human Cu/Zn Superoxide Dismutase, a Model of Down Syndrome. Free Radical Biology & Medicine, 40, 1971-1980. http://dx.doi.org/10.1016/j.freeradbiomed.2006.01.029
Gahtan, E., Auerbach, J.M., Groner, Y. and Segal, M. (1998) Reversible Impairment of Long-Term Potentiation in Transgenic Cu/Zn-SOD Mice. European Journal of Neuroscience, 10, 538-544. http://dx.doi.org/10.1046/j.1460-9568.1998.00058.x
Colas, D., London, J., Gharib, A., Cespuglio, R. and Sarda, N. (2004) Sleep-Wake Architecture in Mouse Models for Down Syndrome. Neurobiology of Disease, 16, 291-299. http://dx.doi.org/10.1016/j.nbd.2004.03.009
Kotulska, K., LePecheur, M., Marcol, W., Lewin-Kowalik, J., Larysz-Brysz, M., Paly, E., Matuszek, I. and London, J. (2006) Overexpression of Copper/Zinc-Superoxide Dismutase in Transgenic Mice Markedly Impairs Regeneration and Increases Development of Neuropathic Pain after Sciatic Nerve Injury. Journal of Neuroscience Research, 84, 1091-1097. http://dx.doi.org/10.1002/jnr.21000
Thireau, J., Poisson, D., Zhang, B.L., Gillet, L. and Le Pécheur, M. (2008) Increased Heart Rate Variability in Mice Overexpressing the Cu/Zn Superoxide Dismutase. Free Radical Biology & Medicine, 45, 396-403. http://dx.doi.org/10.1016/j.freeradbiomed.2008.04.020
Xing, J., Yu, Y. and Rando, T.A. (2002) The Modulation of Cellular Susceptibility to Oxidative Stress: Protective and Destructive Actions of Cu,Zn-Superoxide Dismutase. Neurobiology of Disease, 10, 234-246. http://dx.doi.org/10.1006/nbdi.2002.0504
Chan, P.H., Chu, L., Chen, S.F., Carlson, E.J. and Epstein, C.J. (1990) Reduced Neurotoxicity in Transgenic Mice Overexpressing Human Copper-Zinc-Superoxide Dismutase. Stroke, 21, 80-82.
Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A.B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C.J. and Cadet, J.L. (1992) Transgenic Mice with Increased Cu/Zn-Superoxide Dismutase Activity Are Resistant to N-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity. The Journal of Neuroscience, 12, 1658-1667.
Busciglio, J. and Yankner, B.A. (1995). Apoptosis and Increased Generation of Reactive Oxygen Species in Down’s Syndrome Neurons in Vitro. Nature, 378, 776-779. http://dx.doi.org/10.1038/378776a0
Borg, J. and London, J. (2002) Copper/Zinc Superoxide Dismutase Overexpression Promotes Survival of Cortical Neurons Exposed to Neurotoxins in Vitro. Journal of Neuroscience Research, 70, 180-189. http://dx.doi.org/10.1002/jnr.10404
Chevion, M., Berenshtein, E. and Stadtman, E.R. (2000) Human Studies Related to Protein Oxidation: Protein Carbonyl Content as a Marker of Damage. Free Radical Research, 33, S99-S108.
Tanaka, K. (1998) Molecular Biology of the Proteasome. Biochemical and Biophysical Research Communications, 247, 537-541. http://dx.doi.org/10.1006/bbrc.1998.8617
Shringarpure, R., Grune, T. and Davies, K.J. (2001) Protein Oxidation and 20S Proteasome-Dependent Proteolysis in Mammalian Cells. Cellular and Molecular Life Sciences, 58, 442-450. http://dx.doi.org/10.1007/pl00000787
Höhn, A., König, J. and Grune, T. (2013) Protein Oxidation in Aging and the Removal of Oxidized Proteins. Journal of Proteomics, 92, 132-159. http://dx.doi.org/10.1016/j.jprot.2013.01.004
Catalgol, B. and Grune, T. (2012) Proteasome and Neurodegenerative Diseases. Proteasome and Neurodegenerative Diseases. Progress in Molecular Biology and Translational Science, 109, 397-414. http://dx.doi.org/10.1016/B978-0-12-397863-9.00011-0
Ben-Nissan, G. and Sharon, M. (2014) Regulating the 20S Proteasome Ubiquitine-Independent Degradation Pathway. Biomolecules, 4, 862-884. http://dx.doi.org/10.3390/biom4030862
Adams, J. (2003) The Proteasome: Structure, Function, and Role in the Cell. Cancer Treatment Reviews, 29, 3-9. http://dx.doi.org/10.1016/S0305-7372(03)00081-1
Reinheckel, T., Sitte, N., Ullrich, O., Kuckelkorn, U., Davies, K.J. and Grune, T. (1998) Comparative Resistance of the 20S and 26S Proteasome to Oxidative Stress. Biochemical Journal, 335, 637-642. http://dx.doi.org/10.1042/bj3350637
Raynes, R., Pomatto, L.C.D. and Davies, K.J.A. (2016) Degradation of Oxidized Proteins by the Proteasome: Distinguishing between the 20S, 26S, and Proteolytic Pathways. Molecular Aspects of Medicine, Epub Ahead of Print.
Keller, J.N., Hanni, K.B. and Markesbery, W.R. (2000) Possible Involvement of Proteasome Inhibition in Aging: Implications for Oxidative Stress. Mechanisms of Ageing and Development, 113, 61-70. http://dx.doi.org/10.1016/S0047-6374(99)00101-3
Chondrogianni, N., Stratford, F.L., Trougakos, I.P., Friguet, B., Rivett, A.J. and Gonos, E.S. (2003) Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts: Induction of a Senescence-Like Phenotype upon Its Inhibition and Resistance to Stress upon Its Activation. The Journal of Biological Chemistry, 278, 28026-28037. http://dx.doi.org/10.1074/jbc.M301048200
Medina, D.X., Caccamo, A. and Oddo, S. (2012) Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity. Brain Pathology, 21, 140-149. http://dx.doi.org/10.1111/j.1750-3639.2010.00430.x
Chondrogianni, N., Sakellari, M., Lefaki, M., Papaevgeniou, N. and Gonos, E.S. (2014) Proteasome Activation Delays Aging in Vitro and in Vivo. Free Radical Biology & Medicine, 71, 303-320. http://dx.doi.org/10.1016/j.freeradbiomed.2014.03.031
Gonos, E. (2014) S4-3—Proteasome Activation as a Novel Anti-Aging Strategy. Free Radical Biology & Medicine, 75, S7. http://dx.doi.org/10.1016/j.freeradbiomed.2014.10.842
Head, E., Silverman, W., Patterson, D. and Lott, I.T. (2012) Aging and Down Syndrome. Current Gerontology and Geriatrics Research, 2012, Article ID: 412536. http://dx.doi.org/10.1155/2012/412536
Glasson, E.J., Dye, D.E. and Bittles, A.H. (2014) The Triple Challenges Associated with Age-Related Comorbidities in Down syndrome. The Journal of Intellectual Disability Research, 58, 393-398. http://dx.doi.org/10.1111/jir.12026
Paris, D., Toyama, K., Mégarbané, A., Casanova, P.M., Sinet, P.M. and London, J. (1996) Rapid Fluorescence in situ Hybridization on Interphasic Nuclei to Discriminate between Homozygous and Heterozygous Transgenic Mice. Transgenic Research, 5, 397-403. http://dx.doi.org/10.1007/BF01980204
Le Pecheur, M., Bourdon, E., Paly, E., Farout, L., Friguet, B. and London, J. (2005) Oxidized SOD1 Alters Proteasome Activities in Vitro and in the Cortex of SOD1 Overexpressing Mice. FEBS Letters, 579, 3613-3618. http://dx.doi.org/10.1016/j.febslet.2005.05.048
Tomaru, U., Tsuji, T., Kiuchi, S., Ishizu, A., Suzuki, A., Otsuka, N., Ito, T., Ikeda, H., Fukasawa, Y. and Kasahara, M. (2015) Decreased Expression of Thymus-Specific Proteasome Subunit β5t in Down Syndrome Patients. Histopathology, 67, 235-244. http://dx.doi.org/10.1111/his.12642
Bulteau, A.L., Szweda, L.I. and Friguet, B. (2002) Age-Dependent Declines in Proteasome activity in the Heart. Archives of Biochemistry and Biophysics, 397, 298-304. http://dx.doi.org/10.1006/abbi.2001.2663
Li, F., Zhang, L., Craddock, J., Bruce-Keller, A.J., Dasuri, K., Nguyen, A. and Keller, J.N. (2008) Aging and Dietary Restriction Effects on Ubiquitination, Sumoylation, and the Proteasome in the Heart. Mechanisms of Ageing and Development, 129, 515-521. http://dx.doi.org/10.1016/j.mad.2008.04.007
Zeng, B.Y., Medhurst, A.D., Jackson, M., Rose, S. and Jenner, P. (2005) Proteasomal Activity in Brain Differs between Species and Brain Regions and Changes with Age. Mechanisms of Ageing and Development, 126, 760-766. http://dx.doi.org/10.1016/j.mad.2005.01.008
Necchi, D., Lomoio, S. and Scherini, E. (2011) Dysfunction of the Ubiquitin-Proteasome System in the Cerebellum of Aging Ts65Dn Mice. Experimental Neurology, 232, 114-118. http://dx.doi.org/10.1016/j.expneurol.2011.08.009
Chondrogianni, N., Petropoulos, I., Franceschi, C., Friguet, B. and Gonos, E.S. (2000) Fibroblast Cultures from Healthy Centenarians Have an Active Proteasome. Experimental Neurology, 35, 721-728. http://dx.doi.org/10.1016/s0531-5565(00)00137-6
Di Domenico, F., Coccia, R., Cocciolo, A., Murphy, M.P., Cenini, G., Head, E., Butterfield, D.A., Giorgi, A., Schinina, M.E., Mancuso, C., Cini, C. and Perluigi, M. (2013) Impairment of Proteostasis Network in Down Syndrome Prior to the Development of Alzheimer’s Disease Neuropathology: Redox Proteomics Analysis of Human Brain. Biochimica et Biophysica Acta, 1832, 1249-1259. http://dx.doi.org/10.1016/j.bbadis.2013.04.013